REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.48%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $47,432,237.25

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$571.36

▼ -2.8 (-0.49%)

As of 05/14/2025 05:00 PM ET

Days: 30 | 90 | 365

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Christopher R. Fenimore	CFO	Sell	5,680	$1,205.33	$6,846,274.40	15,305
8/7/2024	Jason Pitofsky	VP	Sell	487	$1,070.00	$521,090.00	4,204
7/11/2024	Joseph J. Larosa	EVP	Sell	1,866	$1,088.95	$2,031,980.70	37,937
7/1/2024	Arthur F. Ryan	Director	Sell	100	$1,059.24	$105,924.00	17,882
7/1/2024	Marion Mccourt	EVP	Sell	1,137	$1,047.11	$1,190,564.07	12,931
6/24/2024	Bonnie L. Bassler	Director	Sell	756	$1,062.00	$802,872.00	1,382
6/14/2024	Michael S. Brown	Director	Sell	1,535	$1,040.00	$1,596,400.00	1,382
6/11/2024	Leonard S. Schleifer	CEO	Sell	9,064	$1,015.43	$9,203,857.52	55,134
6/6/2024	Leonard S. Schleifer	CEO	Sell	787	$1,015.02	$798,820.74	64,198
6/5/2024	Bonnie L. Bassler	Director	Sell	827	$1,011.00	$836,097.00	1,382
5/28/2024	Michael S. Brown	Director	Sell	1,172	$974.86	$1,142,535.92	1,382
5/17/2024	Leonard S. Schleifer	CEO	Sell	22,830	$979.23	$22,355,820.90	466,877
5/14/2024	Leonard S. Schleifer	CEO	Sell	25,000	$979.25	$24,481,250.00	408,200
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644

See Full Table

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2025	B. Metzler seel. Sohn & Co. AG	3,225	$2.05M	0.0%	-4.0%	0.003%
5/14/2025	Paces Ferry Wealth Advisors LLC	520	$0.33M	0.2%	+14.8%	0.000%
5/14/2025	Guggenheim Capital LLC	33,066	$20.97M	0.2%	-12.1%	0.030%
5/14/2025	CreativeOne Wealth LLC	520	$0.33M	0.0%	+16.6%	0.000%
5/14/2025	Ieq Capital LLC	8,219	$5.21M	0.0%	+114.1%	0.008%
5/14/2025	Gamco Investors INC. ET AL	589	$0.37M	0.0%	+4.6%	0.001%
5/14/2025	Samalin Investment Counsel LLC	873	$0.55M	0.2%	+15.5%	0.001%
5/14/2025	Gabelli Funds LLC	1,808	$1.15M	0.0%	-4.9%	0.002%
5/14/2025	Rafferty Asset Management LLC	44,702	$28.35M	0.1%	-6.1%	0.041%
5/14/2025	Epoch Investment Partners Inc.	207,456	$131.58M	0.7%	+5.2%	0.190%
5/14/2025	Ceredex Value Advisors LLC	31,025	$19.68M	0.4%	N/A	0.028%
5/14/2025	FORA Capital LLC	5,447	$3.46M	0.4%	+113.4%	0.005%
5/14/2025	PKS Advisory Services LLC	333	$0.21M	0.1%	N/A	0.000%
5/14/2025	Harvest Portfolios Group Inc.	82,924	$52.59M	1.6%	+16.2%	0.076%
5/14/2025	Caisse DE Depot ET Placement DU Quebec	222,614	$141.19M	0.3%	-28.2%	0.204%
5/14/2025	Corebridge Financial Inc.	33,424	$21.20M	0.1%	-3.5%	0.031%
5/14/2025	Kayne Anderson Rudnick Investment Management LLC	8,566	$5.43M	0.0%	+62.3%	0.008%
5/14/2025	Comerica Bank	14,976	$9.50M	0.0%	+5.6%	0.014%
5/14/2025	Freedom Investment Management Inc.	1,082	$0.69M	0.1%	+34.4%	0.001%
5/14/2025	Synovus Financial Corp	2,097	$1.33M	0.0%	+13.5%	0.002%
5/14/2025	MetLife Investment Management LLC	27,697	$17.57M	0.1%	-1.9%	0.025%
5/14/2025	ICONIQ Capital LLC	376	$0.24M	0.0%	-16.1%	0.000%
5/14/2025	Dodge & Cox	2,324,085	$1.47B	0.8%	+0.1%	2.126%
5/14/2025	Jump Financial LLC	44,428	$28.18M	0.4%	+136.4%	0.041%
5/14/2025	SVB Wealth LLC	625	$0.40M	0.0%	-37.0%	0.001%
5/14/2025	APG Asset Management N.V.	77,407	$45.45M	0.1%	-5.3%	0.071%
5/14/2025	Smartleaf Asset Management LLC	860	$0.55M	0.1%	-9.7%	0.001%
5/14/2025	Biondo Investment Advisors LLC	8,461	$5.37M	0.8%	+867.0%	0.008%
5/14/2025	Northwestern Mutual Wealth Management Co.	4,133	$2.62M	0.0%	+7.7%	0.004%
5/14/2025	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	20,669	$13.11M	0.1%	-0.4%	0.019%
5/14/2025	Haverford Trust Co	344	$0.22M	0.0%	+7.8%	0.000%
5/14/2025	Groupe la Francaise	8,027	$4.92M	0.1%	-50.0%	0.007%
5/14/2025	AlphaQuest LLC	2,085	$1.32M	0.1%	-6.8%	0.002%
5/14/2025	Kestra Advisory Services LLC	4,905	$3.11M	0.0%	-27.2%	0.004%
5/14/2025	Allstate Corp	3,525	$2.24M	0.1%	+10.3%	0.003%
5/14/2025	1832 Asset Management L.P.	2,092	$1.33M	0.0%	-56.3%	0.002%
5/14/2025	Compound Planning Inc.	725	$0.46M	0.0%	+17.9%	0.001%
5/14/2025	Monetary Management Group Inc.	1,107	$0.70M	0.2%	-38.1%	0.001%
5/14/2025	Hobbs Group Advisors LLC	932	$0.59M	0.2%	N/A	0.001%
5/14/2025	Ameriprise Financial Inc.	340,145	$215.57M	0.1%	+4.2%	0.311%
5/14/2025	Norinchukin Bank The	8,378	$5.31M	0.1%	+44.2%	0.008%
5/14/2025	CW Advisors LLC	1,428	$0.92M	0.0%	N/A	0.001%
5/14/2025	Summit Financial LLC	10,596	$6.72M	0.2%	+0.6%	0.010%
5/14/2025	Kaufman Rossin Wealth LLC	344	$0.22M	0.2%	N/A	0.000%
5/14/2025	Price T Rowe Associates Inc. MD	2,175,026	$1.38B	0.2%	+4.3%	1.990%
5/14/2025	Martingale Asset Management L P	11,596	$7.36M	0.2%	-42.6%	0.011%
5/14/2025	Candriam S.C.A.	214,941	$136.32M	0.9%	-17.8%	0.197%
5/14/2025	Dorsey & Whitney Trust CO LLC	361	$0.23M	0.0%	-43.2%	0.000%
5/14/2025	Aspire Growth Partners LLC	623	$0.40M	0.4%	+5.4%	0.001%
5/14/2025	Erste Asset Management GmbH	37,033	$23.57M	0.3%	-8.3%	0.034%
5/14/2025	Humankind Investments LLC	1,430	$0.91M	0.2%	+10.2%	0.001%
5/14/2025	EntryPoint Capital LLC	653	$0.41M	0.2%	+41.0%	0.001%
5/14/2025	Bowen Hanes & Co. Inc.	415	$0.26M	0.0%	-10.8%	0.000%
5/14/2025	Credit Agricole S A	5,898	$3.74M	0.0%	-47.0%	0.005%
5/14/2025	Banco Bilbao Vizcaya Argentaria S.A.	38,168	$24.22M	0.2%	+1.7%	0.035%
5/14/2025	Greenwoods Asset Management Hong Kong Ltd.	4,750	$3.01M	0.1%	+37.7%	0.004%
5/14/2025	Groupama Asset Managment	90,612	$57.75M	0.5%	+12.8%	0.083%
5/14/2025	Van Lanschot Kempen Investment Management N.V.	5,467	$3.47M	0.0%	+2.8%	0.005%
5/14/2025	JT Stratford LLC	3,185	$2.02M	0.4%	-6.4%	0.003%
5/14/2025	BI Asset Management Fondsmaeglerselskab A S	4,508	$2.86M	0.0%	-2.4%	0.004%
5/14/2025	Legacy Financial Advisors Inc.	992	$0.63M	0.1%	+36.3%	0.001%
5/14/2025	Colonial Trust Advisors	50	$32K	0.0%	N/A	0.000%
5/14/2025	Quantbot Technologies LP	1,764	$1.12M	0.0%	+234.1%	0.002%
5/14/2025	RWA Wealth Partners LLC	17,970	$11.40M	0.1%	-2.5%	0.016%
5/14/2025	Wellington Management Group LLP	17,414	$11.04M	0.0%	-88.3%	0.016%
5/14/2025	Korea Investment CORP	65,940	$41.82M	0.1%	-15.7%	0.060%
5/13/2025	Qtron Investments LLC	1,945	$1.23M	0.2%	+37.5%	0.002%
5/13/2025	Northern Trust Corp	1,001,750	$635.34M	0.1%	-5.0%	0.916%
5/13/2025	Brooklyn Investment Group	510	$0.32M	0.1%	+29.4%	0.000%
5/13/2025	Freestone Capital Holdings LLC	538	$0.34M	0.0%	-13.4%	0.000%
5/13/2025	Algert Global LLC	454	$0.29M	0.0%	N/A	0.000%
5/13/2025	Corient IA LLC	500	$0.32M	0.2%	N/A	0.000%
5/13/2025	Cambiar Investors LLC	50,310	$31.91M	1.4%	N/A	0.046%
5/13/2025	Steward Partners Investment Advisory LLC	5,368	$3.41M	0.0%	+16.0%	0.005%
5/13/2025	Raymond James Financial Inc.	111,509	$70.72M	0.0%	+21.9%	0.102%
5/13/2025	Cresset Asset Management LLC	4,143	$2.63M	0.0%	-668.3%	0.004%
5/13/2025	Alliance Wealth Advisors LLC UT	633	$0.40M	0.1%	+81.9%	0.001%
5/13/2025	Forvis Mazars Wealth Advisors LLC	3,394	$2.15M	0.1%	+4.3%	0.003%
5/13/2025	Tocqueville Asset Management L.P.	85,929	$54.50M	0.9%	N/A	0.079%
5/13/2025	State of New Jersey Common Pension Fund D	36,246	$22.99M	0.1%	-9.0%	0.033%
5/13/2025	Oak Grove Capital LLC	3,030	$1.92M	0.4%	+3.4%	0.003%
5/13/2025	American Century Companies Inc.	722,467	$458.21M	0.3%	+2.1%	0.661%
5/13/2025	Ethic Inc.	7,081	$4.37M	0.1%	-33.6%	0.006%
5/13/2025	Element Capital Management LLC	4,265	$2.71M	0.7%	N/A	0.004%
5/13/2025	Aberdeen Group plc	245,197	$155.65M	0.3%	+30.1%	0.224%
5/13/2025	Dimensional Fund Advisors LP	571,187	$362.27M	0.1%	-2.7%	0.522%
5/13/2025	Horizon Investments LLC	1,634	$1.04M	0.0%	+3.7%	0.001%
5/13/2025	Fox Run Management L.L.C.	1,734	$1.10M	0.2%	N/A	0.002%
5/13/2025	Kovitz Investment Group Partners LLC	6,929	$4.40M	0.0%	+80.5%	0.006%
5/13/2025	Fjarde AP Fonden Fourth Swedish National Pension Fund	33,252	$21.09M	0.3%	+8.5%	0.030%
5/13/2025	Sienna Gestion	9,165	$5.65M	0.5%	-5.8%	0.008%
5/13/2025	E Fund Management Co. Ltd.	4,912	$3.12M	0.1%	+53.6%	0.004%
5/13/2025	Tokio Marine Asset Management Co. Ltd.	15,062	$9.55M	0.3%	+22.9%	0.014%
5/13/2025	S Bank Fund Management Ltd	1,038	$0.66M	0.1%	N/A	0.001%
5/13/2025	Gulf International Bank UK Ltd	6,327	$4.01M	0.1%	-24.9%	0.006%
5/13/2025	National Pension Service	253,046	$160.49M	0.2%	+8.9%	0.231%
5/13/2025	LGT Fund Management Co Ltd.	658	$0.42M	0.0%	+17.5%	0.001%
5/13/2025	Russell Investments Group Ltd.	146,740	$93.08M	0.1%	+6.9%	0.134%
5/13/2025	Prudential PLC	1,726	$1.10M	0.0%	-50.3%	0.002%
5/13/2025	Resona Asset Management Co. Ltd.	38,436	$24.39M	0.1%	+3.3%	0.035%

Data available starting January 2016

See Full Table

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $571.36

$567.59

$580.56

50 Day Range

MA: $605.64

$527.78

$744.83

52 Week Range

Now: $571.36

$520.50

$1,211.20

Volume

1,663,574 shs

Average Volume

780,252 shs

Market Capitalization

$62.46 billion

P/E Ratio

14.93

Dividend Yield

0.16%

Beta

0.43

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Jason Pitofsky (VP)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Michael S Brown (Director)
Huda Y Zoghbi (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 8.61%
Dodge & Cox — 2.13%
Price T Rowe Associates Inc. MD — 1.99%
Goldman Sachs Group Inc. — 1.05%
Northern Trust Corp — 0.92%
Invesco Ltd. — 0.78%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
Wellington Management Group LLP
Bank Julius Baer & Co. Ltd Zurich
Caisse DE Depot ET Placement DU Quebec
Northern Trust Corp
Candriam S.C.A.
Victory Capital Management Inc.
Zurcher Kantonalbank Zurich Cantonalbank
Jefferies Financial Group Inc.
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Plew Daniel P Van (EVP)
Marion Mccourt (EVP)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
GAMMA Investing LLC
Nuveen LLC
Pacer Advisors Inc.
Assenagon Asset Management S.A.
Goldman Sachs Group Inc.
Vanguard Group Inc.
Retirement Systems of Alabama
Price T Rowe Associates Inc. MD